Login / Signup

Coronavirus disease 2019 (COVID-19) as a potential trigger for benign recurrent intrahepatic cholestasis.

Turan CalhanElif Yivli
Published in: Clinical case reports (2022)
Benign recurrent intrahepatic cholestasis (BRIC) is a rare disease characterized by recurrent severe itching and jaundice. Coronavirus disease 2019 (COVID-19) is a multisystemic acute viral disease and the liver is frequently affected. Here, we wanted to present a BRIC case triggered by COVID-19 infection, discussing it together with current information.
Keyphrases
  • coronavirus disease
  • drug induced
  • sars cov
  • respiratory syndrome coronavirus
  • liver failure
  • early onset
  • health information
  • climate change
  • hepatitis b virus
  • human health